0001214659-22-003987.txt : 20220315
0001214659-22-003987.hdr.sgml : 20220315
20220315191226
ACCESSION NUMBER: 0001214659-22-003987
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220315
FILED AS OF DATE: 20220315
DATE AS OF CHANGE: 20220315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GUSTAFSON MARK
CENTRAL INDEX KEY: 0001303996
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40483
FILM NUMBER: 22742784
MAIL ADDRESS:
STREET 1: 10691 ROSECROFT CRESCENT
CITY: RICHMOND
STATE: A1
ZIP: V7A 2H9
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alzamend Neuro, Inc.
CENTRAL INDEX KEY: 0001677077
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811822909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 3802 SPECTRUM BLVD,
STREET 2: SUITE C112C
CITY: TAMPA
STATE: FL
ZIP: 33612
BUSINESS PHONE: 844-722-6333
MAIL ADDRESS:
STREET 1: 3802 SPECTRUM BLVD,
STREET 2: SUITE C112C
CITY: TAMPA
STATE: FL
ZIP: 33612
4
1
marketforms-55804.xml
PRIMARY DOCUMENT
X0306
4
2022-03-15
0001677077
Alzamend Neuro, Inc.
ALZN
0001303996
GUSTAFSON MARK
3500 LENOX RD NE, SUITE 1500
ATLANTA
GA
30326
true
false
false
false
Common Stock
2022-03-15
4
M
false
50000
0
A
80000
D
Restricted Stock Grant
2022-03-15
4
M
false
50000
0
D
2022-03-15
Common Stock
50000
0
D
Represents the vesting of restricted stock.
Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc.
2,778 and 47,222 restricted shares previously vested on September 13, 2021 and October 13, 2021, respectively, with the final 50,000 shares of restricted stock vesting on March 15, 2022.
/s/ Mark Gustafson
2022-03-15